Allergan Alphagan P
Executive Summary
Brimonidine ophthalmic solution .15%, approved March 16, will be launched by fall for lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Alphagan P, preserved with Purite, has comparable efficacy to Alphagan .2%, while reducing the risk of side effects